AIDS Drug Assistance Program

This blog focuses on the federal commitment to fully fund the AIDS Drug Assistance Program (ADAP) for people living with HIV/AIDS.

Showing posts with label New England Journal of Medicine. Show all posts

Showing posts with label New England Journal of Medicine. Show all posts

Thursday, June 4, 2026

Gonorrhea is the Chink in DoxyPEP's Armor

By: Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy Recent studies have shown that DoxyPEP (doxycycline post-exposure proph...

Thursday, November 3, 2022

Start Antiretroviral Therapy Sooner Than Later

By: Ranier Simons , ADAP Blog Guest Contributor As medical science strives towards eradicating HIV, research and discourse regarding treatm...

Thursday, September 1, 2022

HIV & Monkeypox: What Patients Need to Know

By: Ranier Simons , ADAP Blog Guest Contributor Presently, there is not much research data concerning monkeypox and HIV. Due to the novelty...

View web version

About Me

ADAP Advocacy

View my complete profile

Powered by Blogger.